Copyright
©The Author(s) 2015.
World J Gastrointest Pathophysiol. Aug 15, 2015; 6(3): 79-85
Published online Aug 15, 2015. doi: 10.4291/wjgp.v6.i3.79
Published online Aug 15, 2015. doi: 10.4291/wjgp.v6.i3.79
Table 1 The Israel Ministry of Health protocol for donor screening for fecal microbial transplantation
| Patient eligibility for FMT |
| 1 Questionnaire to exclude potentially transmissible diseases |
| (1) Practices protected sexual intercourse (or in a monogamous relationship with a healthy partner) |
| (2) Has not had tattooing in the previous six months |
| (3) Does not have any known infectious diseases |
| (4) No drug abuse |
| (5) Has not travelled to the Far-East, India, Africa, Central or South America within the previous six months |
| (6) Has no known autoimmune disease |
| (7) There is no history of any gastrointestinal disease, including inflammatory bowel disease, celiac disease or irritable bowel disease |
| (8) Has not had any previous bowel resection |
| (9) There is no history of infectious diarrhea in the previous 12 mo |
| (10) Has not received antibiotic therapy in the previous 2 mo |
| 2 Laboratory tests |
| (1) Negative stool culture |
| (2) Negative stool microscopy, including Giardia, Cryptosporidium and Isospora beli |
| (3) Negative Clostridium difficile toxin |
| (4) Negative serological testing for HIV, HBV, HCV, HAV, VDRL, CMV |
| (5) Negative test for Helicobacter pylori (either C13 urea breath testing, stool antigen or serum antibodies) |
- Citation: Malnick S, Melzer E. Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol 2015; 6(3): 79-85
- URL: https://www.wjgnet.com/2150-5330/full/v6/i3/79.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v6.i3.79
